Ligand Pharma (LGND) Tops Q2 EPS by 84c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Ligand Pharma (LGND) Tops Q2 EPS by 84c

Ligand Reports Second Quarter 2023 Financial Results

August 8, 2023 4:01 PM EDT

Conference Call Begins at 4:30 p.m. Eastern Time Today

SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and six months ended June 30, 2023, and provided an operating forecast and business updates. Ligand management will host a conference call today beginning at 4:30 p.m. Eastern time to discuss this announcement and answer questions.

We are pleased to report continued momentum across our portfolio of partnered assets, with multiple positive developments for our commercial and pipeline products, said Todd Davis, CEO... More